Dewey McLin

Director Técnico/Científico/I+D en LONGBOARD PHARMACEUTICALS, INC. .

Health Technology

Consumer Services

Perfil

Dewey McLin is currently the Vice President & Head-Medical Affairs at Longboard Pharmaceuticals, Inc. Previously, he worked as the Senior Director-Medical Affairs at Greenwich Biosciences, Inc. and as the Vice President-Medical Affairs at Sesen Bio, Inc. for a brief period in 2021.
Dr. McLin completed his undergraduate degree at Indiana University and his doctorate at the University of California, Irvine.

Cargos activos de Dewey McLin

Empresas	Cargo	Inicio
LONGBOARD PHARMACEUTICALS, INC.	Director Técnico/Científico/I+D	-

Todos los cargos activos de Dewey McLin

Antiguos cargos conocidos de Dewey McLin.

Empresas	Cargo	Fin
CARISMA THERAPEUTICS, INC.	Director Técnico/Científico/I+D	01/09/2021
Greenwich Biosciences, Inc. Greenwich Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Greenwich Biosciences, Inc. develops and markets cannabinoid prescription medicines through online. The company is headquartered in Carlsbad, CA.	Director Técnico/Científico/I+D	-

Ver el detalle de la experiencia de Dewey McLin.

Formación de Dewey McLin.

Indiana University	Undergraduate Degree
University of California, Irvine	Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Dewey McLin.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
LONGBOARD PHARMACEUTICALS, INC.	Health Technology

Empresas privadas	2
Sesen Bio, Inc. Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA.	Health Technology
Greenwich Biosciences, Inc. Greenwich Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Greenwich Biosciences, Inc. develops and markets cannabinoid prescription medicines through online. The company is headquartered in Carlsbad, CA.	Health Technology